サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1404992

感染管理の市場規模、シェア、動向分析レポート：タイプ別、最終用途別、地域別、セグメント予測、2023年～2030年

Infection Control Market Size, Share & Trends Analysis Report By Type, By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 120 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
感染管理の市場規模、シェア、動向分析レポート：タイプ別、最終用途別、地域別、セグメント予測、2023年～2030年
出版日: 2023年11月21日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

感染管理市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の感染管理市場規模は2030年までに3,596億米ドルに達する見込みです。

同市場は2023年から2030年にかけてCAGR 6.7％を記録すると予測されています。市場を牽引するのは、世界の院内感染の大幅な増加に関する懸念の高まりです。これにより、感染管理製品の普及が促進されると考えられています。新たな生物製剤の開拓とそれに伴う滅菌製剤への需要の高まりが、市場全体の主な成長要因となっています。ヘルスケア機関は、公衆衛生上の懸念となりうる疾病エピソードの早期認識、報告、隔離、サーベイランスのための戦略の実施に注力しています。

さらに、看護師やその他の医療スタッフ向けに、感染予防と制御に関する集中的なトレーニングモジュールが増加していることから、今後数年間は感染管理製品が幅広く使用される可能性が高いと推測されます。例えば、College of Nurses of Ontario（オンタリオ州看護師協会）は、汚染や感染拡大を減らすための手指衛生の維持に焦点を当てた、標準的慣行に関するガイドラインを発表しました。さらに、米国疾病予防管理センター（CDC）は、外来医療、在宅医療、病院などの幅広い医療現場で医療従事者が感染管理製品を効率的に使用するための消毒・滅菌に関するガイドラインを発表しました。

前述の要因の結果として、感染予防・管理製品の全体的な普及率が大幅に改善されると推定され、市場の需要だけでなく収益もかつてない高さまで促進されると予想されます。感染管理の需要は、COVID-19の蔓延を食い止める必要性からも生じています。政府当局は、公衆衛生を保護し交差汚染を防止するためのガイドラインや政策を定めています。CDCと米国保健社会福祉省は、院内感染の制御を促進するために、基本的な感染管理と予防、機器関連感染、抗生物質耐性、疾患/生物特異的感染、処置関連感染に関する広範なガイドラインのライブラリを提供しています。

戦略的パートナーシップ、M&A、製品開拓など、企業による戦略的イニシアチブの増加が市場成長をさらに促進しています。例えば、Getinge社はXPO Logistics社との提携を拡大し、2021年2月にXPO Logistics社が同社の感染管理事業部門向けにオランダからEMEA地域への倉庫保管・輸送サービスを提供することになった。

感染管理市場レポートハイライト

  • サードパーティの再処理業者の存在感が高まり、滅菌のアウトソーシングがコスト効率につながることから、サービスは飛躍的な成長を遂げると予測されます。
  • 2022年には病院が大きなシェアを占めるが、これは院内感染の増加を抑制するための臨床的緊急性が高いためです。
  • 北米は、病院、医療機器メーカー、製薬会社で大規模な感染予防活動が実施されていることから、2022年時点で市場全体の圧倒的シェアを獲得しています。
  • アジア太平洋市場は、ヘルスケア環境における感染拡大や予防対策に関する意識の高まりから、予測期間中に飛躍的な成長が見込まれます。
  • 競合環境は、地理的拡大やM&Aなどの持続可能性戦略を採用する企業によって特徴づけられ、その結果、市場シェアは大きく伸びています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 感染管理市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 感染管理市場分析ツール
    • 業界分析 - ポーターのファイブフォース分析
    • PESTEL分析

第4章 感染管理市場：タイプの推定・動向分析

  • 感染管理市場：主要ポイント
  • 感染管理市場：動向と市場シェア分析、2022年および2030年
  • 装置
    • 機器市場推計・予測、2018年～2030年
    • 消毒剤
    • 滅菌設備
    • その他
    • サービス
    • サービス市場推計・予測、2018年～2030年
    • 受託滅菌
    • 感染性廃棄物の処理
  • 消耗品
    • 消耗品市場推計・予測、2018年～2030年
    • 感染性廃棄物の処理
    • 消毒剤
    • 滅菌消耗品
    • 個人用保護具
    • その他

第5章 感染管理市場：最終用途推定・動向分析

  • 感染管理市場：主要ポイント
  • 感染管理市場：動向と市場シェア分析、2022年および2030年
  • 病院
    • 病院市場推計・予測、2018年～2030年
  • 医療機器企業
    • 医療機器企業の市場推計・予測、2018年～2030年
  • 臨床検査
    • 臨床検査市場推計・予測、2018年～2030年
  • 製薬会社
    • 製薬会社の市場推計・予測と2018年～2030年
  • その他
    • その他の市場推計・予測、2018年～2030年

第6章 感染管理市場：地域推定・動向分析

  • 地域別の見通し
  • 地域別の感染管理市場：主要ポイント
  • 北米
    • 北米市場推計・予測、2018年～2030年
    • 米国
    • カナダ
  • 欧州
    • 欧州市場推計・予測、2018年～2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋
    • アジア太平洋市場推計・予測、2018年～2030年
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ラテンアメリカ市場推計・予測、2018年～2030年
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 中東・アフリカ市場推計・予測、2018年から2030年
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 会社/競合の分類
    • 3M
    • Belimed AG
    • O&M Halyards or its affiliates.
    • Getinge
    • ASP
    • Sterigenics U.S., LLC - A Sotera Health company
    • MMM Group
    • Cantel Medical Corp.
    • STERIS PLC
    • Midmark Corporation.
    • Medivators Inc.
    • W&H
図表

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 3 North America infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 4 North America infection control market, by region, 2018 - 2030 (USD Billion)
  • Table 5 U.S. infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 6 U.S. infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 7 Canada infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 8 Canada infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 9 Europe infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 10 Europe infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 11 Europe infection control market, by region, 2018 - 2030 (USD Billion)
  • Table 12 Germany infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 13 Germany infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 14 UK infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 15 UK infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 16 France infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 17 France infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 18 Italy infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 19 Italy infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 20 Spain infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 21 Spain infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 22 Sweden infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 23 Sweden infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 24 Norway infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 25 Norway infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 26 Denmark infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 27 Denmark infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 28 Asia Pacific infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 29 Asia Pacific infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 30 Asia Pacific infection control market, by region, 2018 - 2030 (USD Billion)
  • Table 31 China infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 32 China infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 33 Japan infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 34 Japan infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 35 India infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 36 India infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 37 Australia infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 38 Australia infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 39 Thailand infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 40 Thailand infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 41 South Korea infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 42 South Korea infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 43 Latin America infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 44 Latin America infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 45 Latin America infection control market, by region, 2018 - 2030 (USD Billion)
  • Table 46 Brazil infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 47 Brazil infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 48 Mexico infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 49 Mexico infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 50 Argentina infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 51 Argentina infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 52 Middle East and Africa infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 53 Middle East and Africa infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 54 Middle East and Africa infection control market, by region, 2018 - 2030 (USD Billion)
  • Table 55 South Africa infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 56 South Africa infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 57 Saudi Arabia infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 58 Saudi Arabia infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 59 UAE infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 60 UAE infection control market, by end use, 2018 - 2030 (USD Billion)
  • Table 61 Kuwait infection control market, by type, 2018 - 2030 (USD Billion)
  • Table 62 Kuwait infection control market, by end use, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Infection control: market outlook
  • Fig. 9 Infection control competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Infection control market driver impact
  • Fig. 15 Infection control market restraint impact
  • Fig. 16 Infection control market strategic initiatives analysis
  • Fig. 17 Infection control market: Type movement analysis
  • Fig. 18 Infection control market: Type outlook and key takeaways
  • Fig. 19 Equipment market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 20 Disinfectors market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 21 Washers market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 22 Flushes market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 23 Endoscope reprocessors market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 24 Sterilization equipment market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 25 Heat sterilization equipment market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 26 Low temperature equipment market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 27 Radiation sterilization equipment market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 28 Filtration sterilization equipment market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 29 Liquid sterilization equipment market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 30 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 31 Service market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 32 Contract sterilization market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 33 Ethylene oxide sterilization market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 34 E-beam sterilization market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 35 Gamma sterilization market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 36 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 37 Waste disposal market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 38 Consumables market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 39 Infectious waste disposal market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 40 Disinfectants market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 41 Sterilization consumables market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 42 Personal protective equipment market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 43 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 44 Infection control market: End use movement analysis
  • Fig. 45 Infection control market: End use outlook and key takeaways
  • Fig. 46 Hospitals market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 47 Medical device companies market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 48 Clinical laboratories market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 49 Pharmaceutical companies market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 50 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 51 Infection control market: Regional movement analysis
  • Fig. 52 Infection control market: Regional outlook and key takeaways
  • Fig. 53 North America market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 54 U.S. market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 55 Canada market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 56 Europe market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 57 UK market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 58 Germany market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 59 France market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 60 Italy market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 61 Spain market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 62 Sweden market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 63 Norway market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 64 Denmark market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 65 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 66 Japan market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 67 China market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 68 India market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 69 Australia market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 70 Thailand market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 71 South Korea market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 72 Latin America market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 73 Brazil market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 74 Mexico market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 75 Argentina market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 76 MEA market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 77 South Africa market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 78 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 79 UAE market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 80 Kuwait market estimates and forecasts, 2018 - 2030 (USD Billion)
目次
Product Code: GVR-1-68038-822-0

Infection Control Market Growth & Trends:

The global infection control market size is expected to reach USD 359.6 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 6.7% from 2023 to 2030. The market is driven by rising concerns with respect to a significant upsurge in hospital-acquired infections globally. This is believed to facilitate greater penetration of infection control products. An influx in the development of new biologics and subsequent demand for sterilized formulations serve as key growth factors for the overall market. Healthcare organizations are focused on implementing strategies for early recognition, reporting, isolation, and surveillance of disease episodes of potential public health concern.

In addition, an increasing number of intensive training modules, for nurses and other medical staff, on infection prevention and control is presumed to provide high potential for extensive usage of infection control products over the coming years. For instance, College of Nurses of Ontario released guidelines concerning standard practices, that is focused on maintaining hand hygiene to reduce contamination and spread of infection. Furthermore, Centers for Disease Control and Prevention (CDC) has released guidelines for disinfection and sterilization for efficient usage of infection control products by healthcare personnel in a wide array of healthcare settings such as ambulatory care, home care, hospitals, and others.

As a consequence of the aforementioned factors, it is presumed that there will be a significant improvement in the overall penetration rate of infection prevention and control products, which is also anticipated to fuel the market demand as well as the revenue to unprecedented heights. The demand for infection control also stemmed from the need to stop the spread of COVID-19. Governments' authorities prescribed guidelines and policies to safeguard public health and prevent cross-contamination. The CDC, and the U.S. Department of Health and Human Services, provide an extensive library of guidelines on basic infection control and prevention, device-associated infections, antibiotic resistance, disease / organism-specific infection, and procedure-associated infections to promote the control of hospital-acquired infections.

Increase in strategic initiatives undertaken by companies including include strategic partnerships, mergers and acquisitions, and product development are further propelling the market growth. For instance, Getinge expanded its partnership with XPO Logistics under which the latter will provide warehousing and transport services from the Netherlands to the EMEA region for the company's infection control business unit in February 2021.

Infection Control Market Report Highlights:

  • Services are predicted to observe exponential growth as a consequence of the increasing presence of third-party reprocessors and outsourcing of sterilization as a result of associated cost-efficiency
  • Hospitals accounted for a substantial share in 2022, as a consequence of high clinical urgency to curb the growing incidence of hospital-acquired infections
  • North America captured a dominant share of the overall market as of 2022 owing to extensive infection prevention activities being implemented in hospitals, medical device,s and pharmaceutical companies
  • The market in Asia Pacific is projected to witness exponential growth during the forecast period as a result of increasing awareness pertaining to the spread of infections within healthcare settings and measures for prevention
  • The competitive environment is marked by companies adopting sustainability strategies such as geographical expansion and mergers and acquisitions resulting in significant growth in their market share

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. End use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. End use outlook
    • 2.2.3. Regional scope
  • 2.3. Competitive Insights

Chapter 3. Infection Control Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Infection Control Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Infection Control Market: Type Estimates & Trend Analysis

  • 4.1. Infection Control Market: Key Takeaways
  • 4.2. Infection Control Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Equipment
    • 4.3.1. Equipment market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.3.2. Disinfectors
      • 4.3.2.1. Disinfectors market estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.3.2.2. Washers
      • 4.3.2.2.1. Washers market estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.3.2.3. Flushers
      • 4.3.2.3.1. Flushers market estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.3.2.4. Endoscope reprocessors
      • 4.3.2.4.1. Endoscope reprocessors market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.3.3. Sterilization equipment
      • 4.3.3.1. Sterilization equipment market estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.3.3.2. Heat sterilization equipment
      • 4.3.3.2.1. Heat sterilization equipment market estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.3.3.3. Low-temperature equipment
      • 4.3.3.3.1. Low-temperature equipment market estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.3.3.4. Radiation sterilization equipment
      • 4.3.3.4.1. Radiation sterilization equipment market estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.3.3.5. Filtration sterilization equipment
      • 4.3.3.5.1. Filtration sterilization equipment market estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.3.3.6. Liquid sterilization equipment
      • 4.3.3.6.1. Liquid sterilization equipment market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.3.4. Others
      • 4.3.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.3.5. Services
    • 4.3.6. Services market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.3.7. Contract sterilization
      • 4.3.7.1. Contract sterilization market estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.3.7.2. Ethylene oxide sterilization
      • 4.3.7.2.1. Ethylene oxide sterilization market estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.3.7.3. E-Beam sterilization
      • 4.3.7.3.1. E-Beam sterilization market estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.3.7.4. Gamma sterilization
      • 4.3.7.4.1. Gamma sterilization market estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.3.7.5. Others
      • 4.3.7.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.3.8. Infectious waste disposal
      • 4.3.8.1. Infectious waste disposal market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.4. Consumables
    • 4.4.1. Consumables market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.4.2. Infectious waste disposal
      • 4.4.2.1. Infectious waste disposal market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.4.3. Disinfectants
      • 4.4.3.1. Disinfectants market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.4.4. Sterilization consumables
      • 4.4.4.1. Sterilization consumables market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.4.5. Personal protective equipment
      • 4.4.5.1. Personal protective equipment market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.4.6. Others
      • 4.4.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 5. Infection Control Market: End Use Estimates & Trend Analysis

  • 5.1. Infection Control Market: Key Takeaways
  • 5.2. Infection Control Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Hospitals
    • 5.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.4. Medical Device Companies
    • 5.4.1. Medical devices companies market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.5. Clinical Laboratories
    • 5.5.1. Clinical laboratories market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.6. Pharmaceutical Companies
    • 5.6.1. Pharmaceutical companies market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.7. Others
    • 5.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 6. Infection Control Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Infection Control Market by Region: Key Takeaways
  • 6.3. North America
    • 6.3.1. North America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. U.S. market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Canada market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. Europe market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. UK
      • 6.4.2.1. UK market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Germany market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. France
      • 6.4.4.1. France market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Italy market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Spain market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Sweden market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Norway
      • 6.4.8.1. Norway market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.9. Denmark
      • 6.4.9.1. Denmark market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. Japan
      • 6.5.2.1. Japan market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. China
      • 6.5.3.1. China market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. India
      • 6.5.4.1. India market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Australia
      • 6.5.5.1. Australia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Thailand market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.7. South Korea
      • 6.5.7.1. South Korea market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Latin America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Brazil market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Mexico
      • 6.6.3.1. Mexico market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.4. Argentina
      • 6.6.4.1. Argentina market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. MEA market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Saudi Arabia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. South Africa
      • 6.7.3.1. South Africa market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. UAE market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Kuwait market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
    • 7.2.1. 3M
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Belimed AG
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. O&M Halyards or its affiliates.
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Getinge
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. ASP
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Sterigenics U.S., LLC - A Sotera Health company
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. MMM Group
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Cantel Medical Corp.
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. STERIS PLC
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. Midmark Corporation.
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives
    • 7.2.11. Medivators Inc.
      • 7.2.11.1. Company overview
      • 7.2.11.2. Financial performance
      • 7.2.11.3. Product benchmarking
      • 7.2.11.4. Strategic initiatives
    • 7.2.12. W&H
      • 7.2.12.1. Company overview
      • 7.2.12.2. Financial performance
      • 7.2.12.3. Product benchmarking
      • 7.2.12.4. Strategic initiatives